Literature DB >> 24106223

Cost effectiveness of training rural providers to perform joint injections.

Richard E Nelson1, Michael J Battistone, William D Ashworth, Andrea M Barker, Marissa Grotzke, Timothy A Huhtala, Joanne Lafleur, Robert Z Tashjian, Grant W Cannon.   

Abstract

OBJECTIVE: Community-based outpatient clinics (CBOCs) have been established by the Department of Veterans Affairs (VA) to provide primary care services to veterans living in remote and rural regions. The objective of this study was to evaluate the cost effectiveness of training rural primary care providers to perform knee injections in CBOCs, thereby avoiding referring the patient to an urban medical center for an injection by rheumatology or orthopedic specialists.
METHODS: We developed a decision-analysis model to compare costs and outcomes between rural providers who are trained to perform knee injections versus those who are not trained, therefore requiring a referral to a specialist to provide the injections. The model was run separately using costs from the perspective of the VA as well from the patient's perspective. The effectiveness outcome was quality-adjusted life years (QALYs). Probabilistic sensitivity analyses were performed using 10,000 second-order Monte Carlo simulations.
RESULTS: In our base-case analyses, the incremental cost-effectiveness ratio for trained rural providers was $21,190/QALY using costs from the perspective of the VA and $205/QALY using costs from the patient's perspective. Training rural providers was cost effective in 74.4% and 93.6% of 10,000 Monte Carlo simulations at a willingness-to-pay threshold of $50,000/QALY from the perspectives of the VA and the patient, respectively.
CONCLUSION: Training rural providers to perform knee injections for patients with knee pain secondary to osteoarthritis appears cost effective using the commonly used threshold of $50,000/QALY if more than 20 such patients per year are seen at rural primary care clinics. These results provide support for our ongoing efforts to implement such a training program.
Copyright © 2014 by the American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24106223     DOI: 10.1002/acr.22179

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  6 in total

1.  "Mini-Residency" in Musculoskeletal Care: a National Continuing Professional Development Program for Primary Care Providers.

Authors:  Michael J Battistone; Andrea M Barker; Marissa P Grotzke; J Peter Beck; Phillip Lawrence; Grant W Cannon
Journal:  J Gen Intern Med       Date:  2016-06-27       Impact factor: 5.128

2.  Effectiveness of an Interprofessional and Multidisciplinary Musculoskeletal Training Program.

Authors:  Michael J Battistone; Andrea M Barker; Marissa P Grotzke; J Peter Beck; Jeffery T Berdan; Jorie M Butler; Caroline K Milne; Tim Huhtala; Grant W Cannon
Journal:  J Grad Med Educ       Date:  2016-07

3.  Impact of a Musculoskeletal "Mini-Residency" Professional Development Program on Knee Magnetic Resonance Imaging Orders by Primary Care Providers.

Authors:  Erica Mulcaire-Jones; Andrea M Barker; J Peter Beck; Phillip Lawrence; Grant W Cannon; Michael J Battistone
Journal:  J Clin Rheumatol       Date:  2022-03-31       Impact factor: 3.902

4.  Cost-effectiveness of training rural providers to identify and treat patients at risk for fragility fractures.

Authors:  S D Nelson; R E Nelson; G W Cannon; P Lawrence; M J Battistone; M Grotzke; Y Rosenblum; J LaFleur
Journal:  Osteoporos Int       Date:  2014-07-19       Impact factor: 4.507

5.  Orthopedic Care a-CROSS Community.

Authors:  Rajesh Malhotra
Journal:  Indian J Orthop       Date:  2019 Sep-Oct       Impact factor: 1.251

6.  EQ-5D-5L utilities per health states in Spanish population with knee or hip osteoarthritis.

Authors:  Lidia García-Pérez; Vanesa Ramos-García; Pedro Serrano-Aguilar; José Luis Pais-Brito; María Aciego de Mendoza; Jesús Martín-Fernández; Roberto García-Maroto; Juan Carlos Arenaza; Amaia Bilbao
Journal:  Health Qual Life Outcomes       Date:  2019-10-30       Impact factor: 3.186

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.